NORTHERN TRUST CORP - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$24,000
-25.0%
70,5360.0%0.00%
Q4 2021$32,000
-34.7%
70,5360.0%0.00%
Q3 2021$49,000
-5.8%
70,5360.0%0.00%
Q2 2021$52,000
-25.7%
70,5360.0%0.00%
Q1 2021$70,000
+337.5%
70,536
+252.7%
0.00%
Q4 2020$16,000
-11.1%
19,998
+56.8%
0.00%
Q3 2020$18,00012,7510.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2020
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 81,491$116,0000.01%
NewSquare Capital LLC 62$00.00%
UBS Group AG 6,303$9,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 32$00.00%
Jacobi Capital Management LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 39$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 32$00.00%
NORTHERN TRUST CORP 12,751$18,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders